Invention Grant
- Patent Title: Combination therapy involving diaryl macrocyclic compounds
-
Application No.: US16480557Application Date: 2018-01-25
-
Publication No.: US11291667B2Publication Date: 2022-04-05
- Inventor: Jingrong Jean Cui , Dayong Zhai
- Applicant: TURNING POINT THERAPEUTICS, INC.
- Applicant Address: US CA San Diego
- Assignee: TURNING POINT THERAPEUTICS, INC.
- Current Assignee: TURNING POINT THERAPEUTICS, INC.
- Current Assignee Address: US CA San Diego
- Agency: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
- International Application: PCT/US2018/015150 WO 20180125
- International Announcement: WO2018/140554 WO 20180802
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61P35/00 ; A61K31/506 ; A61K31/517 ; A61K31/5377 ; A61K39/395
Abstract:
The present disclosure relates to methods and compositions for treating cancer with a diaryl macrocycle in combination with at least one other cancer therapeutic, such as an EGFR inhibitor.
Public/Granted literature
- US20190381048A1 COMBINATION THERAPY INVOLVING DIARYL MACROCYCLIC COMPOUNDS Public/Granted day:2019-12-19
Information query
IPC分类:
